Proposed deal ranks among the largest corporate legal payouts in US history
Key Highlights
- J&J proposes $5.5 billion settlement over talc lawsuits.
- Deal covers nearly 76,000 ovarian cancer claims.
- Payout could exceed $7 billion if more claimants join.
- Settlement requires approval from at least 95% of eligible claimants.
- Company continues to deny allegations and maintains product safety.
- Previous bankruptcy-based settlement attempts were rejected by US courts.
- Agreement joins the list of America’s biggest corporate legal settlements.
Johnson & Johnson (J&J) has proposed a $5.5 billion settlement to resolve nearly 76,000 lawsuits alleging that its talc-based baby powder products caused ovarian cancer, marking one of the largest product liability settlements in recent years.
Under the proposed agreement, J&J plans to pay approximately $3 billion in 2027, with the remaining amount scheduled for 2028. The settlement will become effective only if at least 95% of eligible claimants agree to participate.
Although the healthcare giant continues to deny the allegations and maintains that its talc products are safe, the company said the settlement is intended to bring more than a decade of litigation to a close and avoid prolonged legal uncertainty.
Legal representatives for the plaintiffs have indicated that the total payout could exceed $7 billion if additional eligible claimants choose to participate, as payments are linked to the number of qualifying claims rather than a fixed compensation cap.
The proposed settlement follows multiple unsuccessful attempts by J&J to resolve the litigation through a bankruptcy strategy involving a subsidiary. Those efforts were rejected by US courts, prompting the company to pursue a broader negotiated settlement.
While substantial, J&J’s proposed payout remains below several landmark corporate settlements in US history. The largest remains the 1998 Master Settlement Agreement, under which major US tobacco companies agreed to pay more than $206 billion over 25 years to compensate states for smoking-related healthcare costs.
Other major settlements include the over $26 billion opioid settlement involving drug distributors and Johnson & Johnson, BP’s $20 billion Deepwater Horizon oil spill settlement, Volkswagen’s $14.7 billion Dieselgate emissions settlement, Bayer’s approximately $11 billion Roundup litigation settlement, Purdue Pharma and the Sackler family’s $7.4 billion opioid settlement, and 3M’s $6 billion settlement over defective military earplugs.
Legal experts note that corporate settlements have grown significantly over the past decade due to increasing class-action lawsuits, mass tort litigation, and the rise of so-called “nuclear verdicts,” where juries award exceptionally large damages. Faced with the uncertainty of lengthy court battles and potentially higher financial liabilities, many companies are opting for negotiated multibillion-dollar settlements.
If finalized, Johnson & Johnson’s agreement will rank among the most significant corporate legal payouts in recent years and further highlight the growing financial risks associated with large-scale product liability litigation.
